Page last updated: 2024-08-25

s20098 and Fatigue Syndrome, Chronic

s20098 has been researched along with Fatigue Syndrome, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amore, M; Benassi, F; Cocito, L; Cordano, C; Emberti Gialloreti, L; Guida, S; Mattei, C; Pardini, M; Primavera, A; Sassos, D; Serrati, C	1

Trials

1 trial(s) available for s20098 and Fatigue Syndrome, Chronic

Article	Year
Agomelatine but not melatonin improves fatigue perception: a longitudinal proof-of-concept study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:6 Topics: Acetamides; Adult; Antidepressive Agents; Fatigue; Fatigue Syndrome, Chronic; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Melatonin; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome	2014

Article

Year

Agomelatine but not melatonin improves fatigue perception: a longitudinal proof-of-concept study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:6

Topics: Acetamides; Adult; Antidepressive Agents; Fatigue; Fatigue Syndrome, Chronic; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Melatonin; Pilot Projects; Psychiatric Status Rating Scales; Quality of Life; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome

2014